Phase 2 N=100 Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19
Severe Acute Respiratory Syndrome
Primary: Proportion of Patients Alive and Free From Respiratory Failure — .891; .884 Proportion of patients
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=28 Vivo Prediabetes Study: Online, Live, and Interactive Strength Training for Older Adults With Prediabetes
PreDiabetes · Older Adults · Muscle Loss
Primary: Leg Strength Assessed Through a 30 Second Chair Rise Test — 14.2 number of chair stands
Phase 2 N=39 A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
Lung Cancer · SCLC
Primary: Phase I: Maximum Tolerated Dose (MTD) — 30 mg/m^2
N/A N=135 Effects of Personalized Physical Rehabilitation in Kidney Transplant Recipients
Kidney Transplant
Primary: Employment Status — 21; 2 Participants
N/A N=14 Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
Peripheral Arterial Disease · Peripheral Artery Disease
Primary: Endothelial Function — 6.13; 3.78 % dilation
Phase 4 N=196 To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients
Type 2 Diabetes Mellitus
Primary: Adverse Events (AEs) Including Serious Adverse Events (SAEs), AEs Leading to Discontinuation (DAE), and Adverse Events of Special Interest — 40; 0; 0; 4 events
N/A N=6 Low Intensity Shock Wave Therapy in the Management of Erectile Dysfunction
Erectile Dysfunction
Primary: Change in Right Resistive Index — 75.67 cm/second
N/A N=398,008 Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Diabetes
Primary: Number of Participants With Established Cardiovascular Disease, or Chronic Kidney Disease, or High Cardiovascular Risk — 127726; 43819; 295882; 99128 Participants
Phase 1 N=11 A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes
Type2diabetes · Endothelial Dysfunction
Primary: Pharmacodynamic Effect — 1.787; 1.911 score on a scale — p=0.1925
N/A N=47 The Effects of Menstrual Cycle Phase on Exercise Treadmill Test Results in Premenopausal Women
Menstrual Cycle · Exercise Treadmill
Primary: ST/HR Index (μV/Bpm) — 1.2; 1.3 μV/Bpm — p=0.521
N/A N=1,753 Encouraging Healthy and Sustainable Dietary Substitutions
Food Selection
Primary: Perceived Message Effectiveness — 2.94; 2.83; 2.98; 1.69 score on a scale — p=<0.001
Phase 2 N=852 Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
Pneumococcal Immunisation · Diphtheria Immunisation · Tetanus Immunisation
Primary: Number of Participants With Immediate Adverse Events (AEs) — 0; 0; 0; 0 Participants
N/A N=281 Oral Cell DNA Adducts in Smokers
Lung Cancer
Primary: Concentration of γ-OH-Acr-dGuo, a Major Acrolein-DNA Adduct — 49.7; 67.1; 46.5 10^9 nucleotides/mL
N/A N=839 Message Testing in Aging African American Smokers
Smoking · Smoking Cessation
Primary: Motivation to Quit Smoking — .3052; .3220; .3202; .4378 score on a scale
Phase 3 N=363 LACunar Intervention (LACI-2) Trial-2
Cerebral Small Vessel Diseases · Stroke, Lacunar
Primary: Feasibility of Phase III Trial — 20; 21; 10; 4 Participants